AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 62 min read$MCK

McKesson and CD&R agree to acquire Option Care Health for $5.8 billion

McKesson (MCK) and Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health (OPCH) for $5.8B, or $32.05 per share, a 37% premium. CD&R will hold 51%, McKesson 49%. OPCH, a home infusion services provider, will remain independent but delist from Nasdaq post-deal. The transaction is expected to close in H1 2027, subject to approvals.

Original reporting
finance.yahoo.com
Published Oct 6, 2026, 12:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 2:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
McKesson and CD&R agree to acquire Option Care Health for $5.8 billion — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$MCKBullishHigh
01

Why it matters

The transaction creates a sizable platform for specialty therapy delivery outside hospitals, aligning with industry trends toward outpatient care.

02

Market read

The $5.8 billion M&A is a material event for both McKesson and Option Care, driving immediate price moves and reshaping the specialty‑care landscape.

03

What to watch

Financing terms and the future of Option Care's existing debt may affect the net benefit to McKesson.

Relevance 9/10Novelty 9/10Timing: today

Background

McKesson, a leading drug distributor, partners with private equity firm CD&R to acquire Option Care Health, the largest independent home‑infusion provider.

Company-level read

Ticker impact

$MCKBullishHigh confidence
Context

McKesson announced a $5.8 billion acquisition of Option Care Health, taking a 49% stake and committing $1.4 billion.

Expected impact

modest upside as investors price in growth potential from the infusion services platform.

Evidence & confidence

Large‑scale M&A with strategic fit; market typically rewards expansion into high‑margin specialty care.

$OPCHBullishHigh confidence
Context

Option Care Health agreed to be acquired for $32.05 a share, a 37% premium, and will be taken private.

Expected impact

upward pressure as the premium is baked in; price may stabilize near the offer level before delisting.

Evidence & confidence

Premium acquisition creates immediate upside; the stock will be removed from Nasdaq, ending further public trading.

Market effects

Sector

Consolidates the home‑infusion market, pressuring peers and encouraging further M&A in specialty‑care services.

Regional

U.S. healthcare services sector may see modest re‑rating as the deal highlights growth in community‑based therapy delivery.

Global

Limited to U.S. healthcare; no direct global macro effect.

Counterpoint

What could challenge this read

Potential integration challenges and regulatory scrutiny could delay value realization, weighing on McKesson.

Key entities

  • Company
    McKesson Corp

    US drug distributor and healthcare services provider.

  • Company
    Option Care Health

    Independent provider of home and alternate‑site infusion services.

  • Private Equity
    Clayton Dubilier & Rice

    Investment firm taking a 51% stake in the combined entity.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

4 outlets

Related articles

OCT 27
$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min
OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min